Biological determinants of endocrine resistance in breast cancer

@article{Musgrove2009BiologicalDO,
  title={Biological determinants of endocrine resistance in breast cancer},
  author={Elizabeth A. Musgrove and Robert Lyndsay Sutherland},
  journal={Nature Reviews Cancer},
  year={2009},
  volume={9},
  pages={631-643}
}
Endocrine therapies targeting oestrogen action (anti-oestrogens, such as tamoxifen, and aromatase inhibitors) decrease mortality from breast cancer, but their efficacy is limited by intrinsic and acquired therapeutic resistance. Candidate molecular biomarkers and gene expression signatures of tamoxifen response emphasize the importance of deregulation of proliferation and survival signalling in endocrine resistance. However, definition of the specific genetic lesions and molecular processes… CONTINUE READING
Highly Influential
This paper has highly influenced 36 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 486 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 159 references

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen

  • M Kok
  • Breast Cancer Res. Treat. 113,
  • 2009

Similar Papers

Loading similar papers…